ATE380346T1 - Differentialdiagnose von störungen vom eisenmetabolismus - Google Patents
Differentialdiagnose von störungen vom eisenmetabolismusInfo
- Publication number
- ATE380346T1 ATE380346T1 AT02777081T AT02777081T ATE380346T1 AT E380346 T1 ATE380346 T1 AT E380346T1 AT 02777081 T AT02777081 T AT 02777081T AT 02777081 T AT02777081 T AT 02777081T AT E380346 T1 ATE380346 T1 AT E380346T1
- Authority
- AT
- Austria
- Prior art keywords
- iron metabolism
- differential diagnosis
- metabolism disorders
- disorders
- iron
- Prior art date
Links
- 208000016286 Iron metabolism disease Diseases 0.000 title abstract 4
- 238000003748 differential diagnosis Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/90—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving iron binding capacity of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating And Analyzing Materials By Characteristic Methods (AREA)
- Coating With Molten Metal (AREA)
- Control Of Steam Boilers And Waste-Gas Boilers (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32252601P | 2001-09-14 | 2001-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380346T1 true ATE380346T1 (de) | 2007-12-15 |
Family
ID=23255267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02777081T ATE380346T1 (de) | 2001-09-14 | 2002-09-12 | Differentialdiagnose von störungen vom eisenmetabolismus |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7601684B2 (de) |
| EP (1) | EP1425589B1 (de) |
| JP (1) | JP2005503559A (de) |
| AT (1) | ATE380346T1 (de) |
| CA (1) | CA2459972A1 (de) |
| DE (1) | DE60223931T2 (de) |
| ES (2) | ES2297011T3 (de) |
| WO (1) | WO2003025583A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459435B2 (en) * | 2002-08-29 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7459436B2 (en) | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| DE10349124A1 (de) | 2003-10-22 | 2005-05-19 | Roche Diagnostics Gmbh | Differenzialdiagnostik mit Hepcidin |
| SI1696947T1 (sl) | 2003-12-19 | 2014-05-30 | F. Hoffmann-La Roche Ag | Uporaba eritropoetina pri zdravljenju motenj porazdelitve železa pri kroničnih vnetnih črevesnih boleznih |
| WO2006062973A2 (en) * | 2004-12-08 | 2006-06-15 | Novartis Ag | Use of organic compounds |
| US7586589B2 (en) * | 2005-09-24 | 2009-09-08 | Beckman Coulter, Inc. | Methods of determination of responsiveness to erythropoietin treatment |
| WO2007084977A2 (en) * | 2006-01-20 | 2007-07-26 | Beckman Coulter, Inc. | Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency |
| JP4949898B2 (ja) * | 2007-03-09 | 2012-06-13 | シスメックス株式会社 | 血球分析装置 |
| WO2011057744A1 (en) | 2009-11-13 | 2011-05-19 | Roche Diagnostics Gmbh | Differential diagnosis of iron deficiencies based on hepcidin and mean hemoglobin content per reticulocyte |
| WO2012037524A2 (en) | 2010-09-16 | 2012-03-22 | The General Hospital Corporation | Red blood cell dynamics for diagnosis |
| US10955423B2 (en) | 2015-12-15 | 2021-03-23 | The General Hospital Corporation | Methods of estimating blood glucose and related systems |
| GB201604806D0 (en) * | 2016-03-22 | 2016-05-04 | Singapore Volition Pte Ltd | Method of identifying a cancer of unknown origin |
| US11293852B2 (en) | 2016-04-07 | 2022-04-05 | The General Hospital Corporation | White blood cell population dynamics |
| WO2021163209A1 (en) * | 2020-02-11 | 2021-08-19 | Quest Diagnostics Investments Llc | System for determining an underlying cause of anemia |
| WO2022102734A1 (ja) * | 2020-11-13 | 2022-05-19 | 株式会社堀場製作所 | 血液検体の判定方法、そのための判定装置とコンピュータープログラム |
-
2002
- 2002-09-12 EP EP02777081A patent/EP1425589B1/de not_active Expired - Lifetime
- 2002-09-12 US US10/242,061 patent/US7601684B2/en not_active Expired - Fee Related
- 2002-09-12 DE DE60223931T patent/DE60223931T2/de not_active Expired - Lifetime
- 2002-09-12 CA CA002459972A patent/CA2459972A1/en not_active Abandoned
- 2002-09-12 ES ES02777081T patent/ES2297011T3/es not_active Expired - Lifetime
- 2002-09-12 WO PCT/EP2002/010250 patent/WO2003025583A2/en not_active Ceased
- 2002-09-12 ES ES07023170T patent/ES2399110T3/es not_active Expired - Lifetime
- 2002-09-12 AT AT02777081T patent/ATE380346T1/de active
- 2002-09-12 JP JP2003529161A patent/JP2005503559A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1425589A2 (de) | 2004-06-09 |
| DE60223931T2 (de) | 2008-04-03 |
| CA2459972A1 (en) | 2003-03-27 |
| EP1425589B1 (de) | 2007-12-05 |
| DE60223931D1 (de) | 2008-01-17 |
| JP2005503559A (ja) | 2005-02-03 |
| US20030073635A1 (en) | 2003-04-17 |
| US7601684B2 (en) | 2009-10-13 |
| WO2003025583A3 (en) | 2003-12-18 |
| WO2003025583A2 (en) | 2003-03-27 |
| ES2399110T3 (es) | 2013-03-25 |
| ES2297011T3 (es) | 2008-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE380346T1 (de) | Differentialdiagnose von störungen vom eisenmetabolismus | |
| ATE440537T1 (de) | Vorrichtungen zum auffangen von interessierenden analyten in tränen | |
| DE60231804D1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen | |
| WO2005037203A3 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
| EP1883349A4 (de) | Verfahren und gerät zur diagnose von atemwegserkrankungen und zur bestimmung des exacerbationsgrades | |
| EP1781303A4 (de) | Verfahren und reagentien zur behandlung von stoffwechselerkrankungen | |
| SG146653A1 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
| ATE442592T1 (de) | Detektion und/oder beobachtung von synuclein- assoziierten krankheiten | |
| CY1109985T1 (el) | Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων | |
| CY1115059T1 (el) | Θεραπευτικα απταμερη χρησιμα στην θεραπευτικη αγωγη διαταραχων σχετιζομενων με συμπληρωμα | |
| GB0117326D0 (en) | Napthoquinone-type inhibitors of protein aggregation | |
| BR0313792A (pt) | Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento | |
| DK1436427T3 (da) | Fremgangsmåde og sammensætning til at vurdere antistofbehandlingsrespons | |
| EP1948280A4 (de) | Biliäre/pankreatisches shunt-vorrichtung und verfahren zur behandlung von metabolischen und anderen erkrankungen | |
| NO20071378L (no) | Tiazolo-naftylsyrer. | |
| EP1539251A4 (de) | Zusammensetzungen und verfahren zur diagnose und therapie von medizinischen erkrankungen mit angiogenese | |
| WO2004107958A3 (en) | Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | |
| EP1593067A4 (de) | Verfahren und vorrichtung zum erwerb über einen verkaufsort | |
| WO2006074450A3 (en) | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases | |
| DE602008004556D1 (de) | Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin | |
| WO2006047475A3 (en) | Detection and analysis of ophthalmically-relevant fluorescent molecules | |
| EP1896042A4 (de) | Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen | |
| EP1865778A4 (de) | Verfahren zur vermeidung von ödem bei der behandlung von stoffwechselstörungen, entzündlichen erkrankungen und herz-kreislauf-erkrankungen | |
| EP1909106A3 (de) | Differenzialdiagnose von Eisenstoffwechselstörungen mittels dreier unabhängiger Parameter und Empfehlungen für die Behandlung dieser Eisenstoffwechselstörungen | |
| WO2007067512A3 (en) | Method for identifying modulators of adprh useful for treating alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1425589 Country of ref document: EP |